Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix


Eralp Y., Saip P., Sakar B., Kucucuk S., Aydiner A., Dincer M., ...More

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol.13, no.4, pp.497-504, 2003 (SCI-Expanded) identifier identifier identifier

Abstract

The aim of this study is to identify the impact of various prognostic factors on survival in patients with recurrent carcinoma of the uterine cervix. Fifty-two patients who were treated with platinum-based chemotherapy for recurrent or metastatic disease were retrospectively evaluated. Twenty-seven patients (90%) had received pelvic radiation as primary treatment.